© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation
Clinic III of Internal Medicine, Laboratory of Muscle Research and Molecular Cardiology, University of Cologne, Cologne, Germany
robert.schwinger{at}medizin.uni-koeln.de
* Corresponding author. Priv.-Doz. Dr. med. Robert H.G. Schwinger, Klinik III für Innere Medizin der Universität zu Köln, Labor für Herzmuskelphysiologie und Molekulare Kardiologie, Joseph-Stelzmannstr. 9, 50924 Köln, Germany. Tel.: +49-221-478-3138; fax: +49-221-478-3746
The cardiac SR Ca2+-ATPase (SERCA2a) regulates intracellular Ca2+-handling and thus, plays a crucial role in initiating cardiac contraction and relaxation. SERCA2a may be modulated through its accessory phosphoprotein phospholamban or by direct phosphorylation through Ca2+/calmodulin dependent protein kinase II (CaMK II). As an inhibitory component phospholamban, in its dephosphorylated form, inhibits the Ca2+-dependent SERCA2a function, while protein kinase A dependent phosphorylation of the phospho-residues serine-16 or Ca2+/calmodulin-dependent phosphorylation of threonine-17 relieves this inhibition. Recent evidence suggests that direct phosphorylation at residue serine-38 in SERCA2a activates enzyme function and enhances Ca2+-reuptake into the sarcoplasmic reticulum (SR). These effects that are mediated through phosphorylation result in an overall increased SR Ca2+-load and enhanced contractility. In human heart failure patients, as well as animal models with induced heart failure, these modulations are altered and may result in an attenuated SR Ca2+-storage and modulated contractility. It is also believed that abnormalities in Ca2+-cycling are responsible for blunting the frequency potentiation of contractile force in the failing human heart. Advanced gene expression and modulatory approaches have focused on enhancing SERCA2a function via overexpressing SERCA2a under physiological and pathophysiological conditions to restore cardiac function, cardiac energetics and survival rate.
KEYWORDS Ca-pump; Calcium (cellular); Contractile function; SR (function)
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M.A. H. Talukder, J. L. Zweier, and M. Periasamy Targeting calcium transport in ischaemic heart disease Cardiovasc Res, December 1, 2009; 84(3): 345 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Sahoo, T. Kim, G. B. Kang, J.-G. Lee, S. H. Eom, and D. H. Kim Characterization of Calumenin-SERCA2 Interaction in Mouse Cardiac Sarcoplasmic Reticulum J. Biol. Chem., November 6, 2009; 284(45): 31109 - 31121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jiao, Y. Bai, T. Akaike, H. Takeshima, Y. Ishikawa, and S. Minamisawa Sarcalumenin is essential for maintaining cardiac function during endurance exercise training Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H576 - H582. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F Frank and J. Muller-Ehmsen Angiostatin: drying out the roots in cardiac muscle Heart, February 1, 2009; 95(4): 269 - 270. [Full Text] [PDF] |
||||
![]() |
M. Lorenz, N. Hellige, P. Rieder, H.-T. Kinkel, C. Trimpert, A. Staudt, S. B. Felix, G. Baumann, K. Stangl, and V. Stangl Positive inotropic effects of epigallocatechin-3-gallate (EGCG) involve activation of Na+/H+ and Na+/Ca2+ exchangers Eur J Heart Fail, May 1, 2008; 10(5): 439 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sathish, F. Leblebici, S. N. Kip, M. A. Thompson, C. M. Pabelick, Y. S. Prakash, and G. C. Sieck Regulation of sarcoplasmic reticulum Ca2+ reuptake in porcine airway smooth muscle Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L787 - L796. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. H. Talukder, A. Kalyanasundaram, L. Zuo, M. Velayutham, Y. Nishijima, M. Periasamy, and J. L. Zweier Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1426 - H1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. H. Talukder, A. Kalyanasundaram, X. Zhao, L. Zuo, P. Bhupathy, G. J. Babu, A. J. Cardounel, M. Periasamy, and J. L. Zweier Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2418 - H2428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Saliaris, L. C. Amado, K. M. Minhas, K. H. Schuleri, S. Lehrke, M. St. John, T. Fitton, C. Barreiro, C. Berry, M. Zheng, et al. Chronic allopurinol administration ameliorates maladaptive alterations in Ca2+ cycling proteins and beta-adrenergic hyporesponsiveness in heart failure Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1328 - H1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Mueller, S. A. Grandy, and S. E. Howlett Protein Kinase A-Mediated Phosphorylation Contributes to Enhanced Contraction Observed in Mice That Overexpress beta-Adrenergic Receptor Kinase-1 J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1307 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bootman, D. R. Higazi, S. Coombes, and H. L. Roderick Calcium signalling during excitation-contraction coupling in mammalian atrial myocytes. J. Cell Sci., October 1, 2006; 119(Pt 19): 3915 - 3925. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Vasanji, E. J. F. Cantor, D. Juric, M. Moyen, and T. Netticadan Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance Am J Physiol Cell Physiol, October 1, 2006; 291(4): C772 - C780. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Logeart, L. Vinet, T. Ragot, M. Heimburger, L. Louedec, J.-B. Michel, B. Escoubet, and J.-J. Mercadier Percutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1773 - H1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bupha-Intr and J. Wattanapermpool Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1101 - H1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Babu, P. Bhupathy, N. N. Petrashevskaya, H. Wang, S. Raman, D. Wheeler, G. Jagatheesan, D. Wieczorek, A. Schwartz, P. M. L. Janssen, et al. Targeted Overexpression of Sarcolipin in the Mouse Heart Decreases Sarcoplasmic Reticulum Calcium Transport and Cardiac Contractility J. Biol. Chem., February 17, 2006; 281(7): 3972 - 3979. [Abstract] [Full Text] [PDF] |
||||
![]() |
B M Mayosi, A Kardos, C H Davies, F Gumedze, A Hovnanian, S Burge, and H Watkins Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure Heart, January 1, 2006; 92(1): 105 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Langenbacher, Y. Dong, X. Shu, J. Choi, D. A. Nicoll, J. I. Goldhaber, K. D. Philipson, and J.-N. Chen Mutation in sodium-calcium exchanger 1 (NCX1) causes cardiac fibrillation in zebrafish PNAS, December 6, 2005; 102(49): 17699 - 17704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W.M. Bassani and R. A. Bassani SERCA upregulation: Breaking the positive feedback in heart failure? Cardiovasc Res, September 1, 2005; 67(4): 581 - 582. [Full Text] [PDF] |
||||
![]() |
T. Dieterle, M. Meyer, Y. Gu, D. D. Belke, E. Swanson, M. Iwatate, J. Hollander, K. L. Peterson, J. Ross Jr., and W. H. Dillmann Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure Cardiovasc Res, September 1, 2005; 67(4): 678 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kaliman, D. Catalucci, J. T. Lam, R. Kondo, J. C. P. Gutierrez, S. Reddy, M. Palacin, A. Zorzano, K. R. Chien, and P. Ruiz-Lozano Myotonic Dystrophy Protein Kinase Phosphorylates Phospholamban and Regulates Calcium Uptake in Cardiomyocyte Sarcoplasmic Reticulum J. Biol. Chem., March 4, 2005; 280(9): 8016 - 8021. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wakisaka, S. Niwano, H. Niwano, J. Saito, T. Yoshida, S. Hirasawa, H. Kawada, and T. Izumi Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure Cardiovasc Res, September 1, 2004; 63(4): 689 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaugg and M. C. Schaub Cellular mechanisms in sympatho-modulation of the heart Br. J. Anaesth., July 1, 2004; 93(1): 34 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fabritz, P. Kirchhof, L. Fortmuller, J. A Auchampach, H. A Baba, G. Breithardt, J. Neumann, P. Boknik, and W. Schmitz Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A3 adenosine receptors Cardiovasc Res, June 1, 2004; 62(3): 500 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Niu, T. Shindo, H. Iwata, S. Iimuro, N. Takeda, Y. Zhang, A. Ebihara, Y. Suematsu, K. Kangawa, Y. Hirata, et al. Protective Effects of Endogenous Adrenomedullin on Cardiac Hypertrophy, Fibrosis, and Renal Damage Circulation, April 13, 2004; 109(14): 1789 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Yarbrough, R. Mukherjee, G. P. Escobar, J. W. Hendrick, J. A. Sample, K. B. Dowdy, J. E. McLean, J. T. Mingoia, F. A. Crawford Jr, and F. G. Spinale Modulation of calcium transport improves myocardial contractility and enzyme profiles after prolonged ischemia-reperfusion Ann. Thorac. Surg., December 1, 2003; 76(6): 2054 - 2061. [Abstract] [Full Text] [PDF] |
||||












